Literature DB >> 18620631

[Happy Audit study. Management of a project on respiratory infection financed by the European community].

Carles Llor, Josep Maria Cots, Lars Bjerrum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18620631      PMCID： PMC7659828          DOI： 10.1157/13124122

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  4 in total

1.  [The APO method--a popular form of quality development in general practice].

Authors:  Anders P Munck; Jens J Damsgaard; Dorte Gilså Hansen; Lars Bjerrum; Jens Søndergaard
Journal:  Ugeskr Laeger       Date:  2002-11-11

2.  [Variability of antibiotic prescribing for respiratory tract infections in two European countries].

Authors:  Carles Llor; Josep Maria Cots; Albert Boada; Lars Bjerrum; Bente Gahrn-Hansen; Anders Munck; Dolors Forés; Marc Miravitlles
Journal:  Enferm Infecc Microbiol Clin       Date:  2005-12       Impact factor: 1.731

3.  Effect of intervention promoting a reduction in antibiotic prescribing by improvement of diagnostic procedures: a prospective, before and after study in general practice.

Authors:  Lars Bjerrum; Josep M Cots; Carl Llor; Núria Molist; Anders Munck
Journal:  Eur J Clin Pharmacol       Date:  2006-09-12       Impact factor: 2.953

4.  Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

Authors:  S Soares; K G Kristinsson; J M Musser; A Tomasz
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226
  4 in total
  1 in total

1.  [Antibiotic prescribing in respiratory tract infections and predictive factors for their use].

Authors:  Carles Llor; Josep María Cots; Lars Bjerrum; Marina Cid; Gloria Guerra; Xavier Arranz; Manuel Gómez; María José Monedero; Juan de Dios Alcántara; Carolina Pérez; Guillermo García; Jesús Ortega; María Luisa Cigüenza; Vicenta Pineda; José Paredes; Juan Luis Burgazzoli; Silvia Hernández
Journal:  Aten Primaria       Date:  2009-08-26       Impact factor: 1.137
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.